Cite
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
MLA
Astrid Louise Bjørn Bennedsen, et al. “An Exploration of Immunohistochemistry-Based Prognostic Markers in Patients Undergoing Curative Resections for Colon Cancer.” BMC Cancer, vol. 22, no. 1, Jan. 2022, pp. 1–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....beaf61dd5eafe5920a14fe7c5a3c62e8&authtype=sso&custid=ns315887.
APA
Astrid Louise Bjørn Bennedsen, Luyi Cai, Rune Petring Hasselager, Aysun Avci Özcan, Khadra Bashir Mohamed, Jens Ole Eriksen, Susanne Eiholm, Michael Bzorek, Anne-Marie Kanstrup Fiehn, Thomas Vauvert F. Hviid, & Ismail Gögenur. (2022). An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer. BMC Cancer, 22(1), 1–19.
Chicago
Astrid Louise Bjørn Bennedsen, Luyi Cai, Rune Petring Hasselager, Aysun Avci Özcan, Khadra Bashir Mohamed, Jens Ole Eriksen, Susanne Eiholm, et al. 2022. “An Exploration of Immunohistochemistry-Based Prognostic Markers in Patients Undergoing Curative Resections for Colon Cancer.” BMC Cancer 22 (1): 1–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....beaf61dd5eafe5920a14fe7c5a3c62e8&authtype=sso&custid=ns315887.